TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs

Vaccine

Volumn 28, Issue 30, 2010, Pages 4713-4718

  Seregin, Alexey V ^a   Yun, Nadezhda E ^a   Poussard, Allison L ^a   Peng, Bi Hung ^a   Smith, Jennifer K ^a   Smith, Jeanon N ^a   Salazar, Milagros ^a   Paessler, Slobodan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Animal models; Hemorrhagic fever; Immune response; Reemerging pathogens; Vaccine

Indexed keywords

LIVE VACCINE; PLASMID DNA; UNCLASSIFIED DRUG; VACCINE TC83; VIRUS GLYCOPROTEIN; VIRUS VACCINE; VIRUS VECTOR; DNA VACCINE; GLYCOPROTEIN; VIRUS ANTIBODY; VIRUS DNA;

ALPHA VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GUINEA PIG; IMMUNE RESPONSE; IMMUNOGENICITY; JUNIN VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPLICON; VACCINATION; ANIMAL; ARENAVIRIDAE INFECTIONS; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CHLOROCEBUS AETHIOPS; GENE VECTOR; GENETICS; HAMSTER; IMMUNOLOGY; PLASMID; SERODIAGNOSIS; SURVIVAL; TELEMETRY; VERO CELL LINE; VIRAL PLAQUE ASSAY; VIROLOGY; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; ARENAVIRIDAE INFECTIONS; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DNA, VIRAL; FEMALE; GENETIC VECTORS; GLYCOPROTEINS; GUINEA PIGS; JUNIN VIRUS; NEUTRALIZATION TESTS; PLAQUE ASSAY; PLASMIDS; REPLICON; SURVIVAL ANALYSIS; TELEMETRY; VACCINES, DNA; VERO CELLS; VIRAL LOAD; VIRAL VACCINES; VIRAL PLAQUE ASSAY;

EID: 77954214468     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.077     Document Type: Article

References (32)

1. Arribalzaga R.A. New epidemic disease due to unidentified germ: nephrotoxic, leukopenic and enanthematous hyperthermia. Dia Med 1955, 27(June (40)):1204-1210.
2. Harrison L.H., Halsey N.A., McKee K.T., Peters C.J., Barrera Oro J.G., Briggiler A.M., et al. Clinical case definitions for Argentine hemorrhagic fever. Clin Infect Dis 1999, 28(May (5)):1091-1094.
3. Buchmeier M.J., de la Torre J.-C., Peters C.J. Arenaviridae: the viruses and their replication. Fields' virology 2007, 1635-1668. Lippincott, Williams and Wilkins, Philadelphia. D.M. Knipe (Ed.).
4. Enria D.A., Barrera Oro J.G. Junin virus vaccines. Curr Top Microbiol Immunol 2002, 263:239-261.
5. Bowen M.D., Peters C.J., Nichol S.T. Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol 1997, 8(December (3)):301-316.
6. Barrera Oro J.G., McKee K.T. Toward a vaccine against Argentine hemorrhagic fever. Bull Pan Am Health Organ 1991, 25(2):118-126.
7. Maiztegui J.I., Fernandez N.J., de Damilano A.J. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 1979, 2(December (8154)):1216-1217.
8. Zacks M.A., Paessler S. Alphavirus virus-based chimeric vaccines against encephalitic alphaviruses. Croat J Infect 2007, 27(4):155-160.
9. Wang E., Petrakova O., Adams A.P., Aguilar P.V., Kang W., Paessler S., et al. Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice. Vaccine 2007, 25(October (43)):7573-7581.
10. Gorchakov R., Volkova E., Yun N., Petrakova O., Seth Linde N., Paessler S., et al. Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins. Virology 2007, 366(September (1)):212-225.
11. Paessler S., Fayzulin R.Z., Anishchenko M., Greene I.P., Weaver S.C., Frolov I. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J Virol 2003, 77(September (17)):9278-9286.
12. Paessler S., Ni H., Petrakova O., Fayzulin R.Z., Yun N., Anishchenko M., et al. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. J Virol 2006, 80(March (6)):2784-2796.
13. Paessler S., Yun N.E., Judy B.M., Dziuba N., Zacks M.A., Grund A.H., et al. Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology 2007, 367(July (2)):307-323.
14. Ni H., Yun N.E., Zacks M.A., Weaver S.C., Tesh R.B., da Rosa A.P., et al. Recombinant alphaviruses are safe and useful serological diagnostic tools. Am J Trop Med Hyg 2007, 76(April (4)):774-781.
15. Pushko P., Geisbert J., Parker M., Jahrling P., Smith J. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol 2001, 75(December (23)):11677-11685.
16. Pushko P., Parker M., Ludwig G.V., Davis N.L., Johnston R.E., Smith J.F. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 1997, 239(2):389-401.
17. Davis N.L., Brown K.W., Greenwald G.F., Zajac A.J., Zacny V.L., Smith J.F., et al. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology 1995, 212(1):102-110.
18. Sambrook J., Russell D.W. Molecular cloning: a laboratory manual 2001, Cold Spring Harbor Laboratory Press, New York. 3 ed.
19. Volkova E., Gorchakov R., Frolov I. The efficient packaging of Venezuelan equine encephalitis virus-specific RNAs into viral particles is determined by nsP1-3 synthesis. Virology 2006, 344(2):315-327.
20. Rice C.M., Levis R., Strauss J.H., Huang H.V. Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. J Virol 1987, 3809-3819.
21. Liljestrom P., Lusa S., Huylebroeck D., Garoff H. In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol 1991, 4107-4113.
22. Sanchez A., Pifat D.Y., Kenyon R.H., Peters C.J., McCormick J.B., Kiley M.P. Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J Gen Virol 1989, 70(May (Pt 5)):1125-1132.
23. Kinney R.M., Johnson B.J.B., Welch J.B., Tsuchiya K.R., Trent D.W. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology 1989, 170(1):19-30.
24. Gorchakov R., Volkova E., Yun N., Petrakova O., Seth Linde N., Paessler S., et al. Comparative analysis of the alphavirus-based vectors expressing Rift valley fever virus glycoproteins. Virology 2007, 366(1):212-225.
25. Agnihothram S.S., York J., Nunberg J.H. Role of the stable signal peptide and cytoplasmic domain of G2 in regulating intracellular transport of the Junin virus envelope glycoprotein complex. J Virol 2006, 80(June (11)):5189-5198.
26. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm. Rep. 2000 April 21;49(RR-4):1-14.
27. Enria D.A., Briggiler A.M., Levis S., Vallejos D., Maiztegui J.I., Canonico P.G. Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. Antiviral Res 1987, 7(July (6)):353-359.
28. Enria D.A., Maiztegui J.I. Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res 1994, 23(January (1)):23-31.
29. Kilgore P.E., Ksiazek T.G., Rollin P.E., Mills J.N., Villagra M.R., Montenegro M.J., et al. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis 1997, 24(April (4)):718-722.
30. Huggins J.W. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis 1989, 11(May-June (Suppl. 4)):S750-S761.
31. Albarino C.G., Bergeron E., Erickson B.R., Khristova M.L., Rollin P.E., Nichol S.T. Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing. J Virol 2009, 83(June (11)):5606-5614.
32. Kenyon R.H., Canonico P.G., Green D.E., Peters C.J. Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs. Antimicrob Agents Chemother 1986, 29(March (3)):521-523.